This initiative plays a vital role in financial management and supports the Government in macroeconomic decision-making by providing comprehensive, timely, and accurate data.
Imexpharm aims for VND2,981 billion in total revenue and VND493.5 billion in profit before tax in 2025, focusing on high-tech products, R&D, and market expansion.